Navigation Links
Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension

be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that lumiracoxib will be approved for sale in the US or any other additional markets, or for any additional indications. Neither can there be any guarantee that lumiracoxib will reach any particular level of sales. In particular, management's expectations regarding lumiracoxib could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; the public debate and regulatory activity regarding COX-2 inhibitors like lumiracoxib; unexpected clinical trial results, including additional analysis of existing clinical data and new clinical data; government, industry, and general public pricing pressures; competition in general; Novartis' ability to obtain or maintain patent or other proprietary intellectual property protection; as well as other risk factors discussed in Novartis AG's Form 20-F filed with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated or expected. Novartis is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceu
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/22/2015)... OTTAWA , May 22, 2015 /CNW/ - More than ... prescribed to treat morning sickness in expectant mothers. Tragically, Thalidomide ... children and families. Support has been provided ... the Government of Canada in 1991 ... the absence of a legal obligation to provide support, we ...
(Date:5/22/2015)... May 22, 2015 Electrophysiologist Kevin Makati, ... traveled to Boston, MA ... 2015 Heart Rhythm Society conference. These scientific sessions ... on the ideas, people and technology that propel ... a hybrid, minimally invasive cardiac operation that combines ...
(Date:5/22/2015)... May 22, 2015  The U.S. Food and ... -- the first biosimilar product approved in ... toward growth in the contract manufacturing organization (CMO) ... industry is geared to the production of small-molecular ... biopharmaceutical products. The healthcare market research publisher,s report, ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... May 27, 2011 CVS Caremark Corporation (NYSE: ... awarded a three-year contract to provide integrated pharmacy benefit ... Service Benefit Plan, also known as the Federal Employee ... Company will continue to provide FEP,s clinical programs and ...
... Kluwer Health today announced that it has completed the ... information and clinical content for pharmacists, clinicians and hospitals ... of strategic acquisitions Wolters Kluwer Health has made in ... strong focus on the point-of-care market. ...
Cached Medicine Technology:CVS Caremark Awarded Integrated 3-Year Blue Cross and Blue Shield Federal Employee Program (FEP) Contract 2Wolters Kluwer Health Completes Acquisition of Lexi-Comp, Inc. 2Wolters Kluwer Health Completes Acquisition of Lexi-Comp, Inc. 3
(Date:5/26/2015)... (PRWEB) May 26, 2015 Many ... added to TheCelebrityDresses.com's formal dress collections recently. Now, ... newly designed dresses, up to 70% off. The ... the world to save hundreds of dollars on ... well-known brand in red carpet fashion special occasion ...
(Date:5/26/2015)... 26, 2015 Pacifica Graduate ... the Memorial Day weekend, celebrating the outstanding accomplishments ... Pacifica’s picturesque Ladera Lane campus, located in the ... alumni traveled to Santa Barbara from all over ... , The 2015 commencement ceremonies featured the ...
(Date:5/26/2015)... Marietta, GA (PRWEB) May 26, 2015 ... Dental Associates are at it again, helping local rescue ... 25, 2015. Local dentists, Kirk Kimmerling DDS, Suzanna ... with veterinarian, Julian Peckich DVM donating 100% of proceeds ... expected to fill the parking lot to help save ...
(Date:5/25/2015)... SAN FRANCISCO (PRWEB) May 26, 2015 According ... people has retinitis pigmentosa , a degenerative eye disease. ... every 150,000 people has paroxysmal kinesigenic dyskinesia , a ... For author Joseph K. Chan , these two diseases ... Chan invites readers to walk in his shoes with his ...
(Date:5/25/2015)... 26, 2015 The National ... Dr. Heather Stanley-Christian as a 2015-2016 inductee ... She is recognized with this prestigious distinction for ... networking organization exclusively for professional women, boasting more ... chapters. , "I'm pleased to welcome Heather into ...
Breaking Medicine News(10 mins):Health News:Cocktail Dresses Inspired by Celebrities on Sale at TheCelebrityDresses.com 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 3Health News:"Rescue Animal Cookout" Announced at Verde Pointe Professional Park on June 25, 2015 2Health News:Joseph K. Chan Finds Faith from Disability in New Autobiography 2Health News:NAPW Inducts Dr. Heather Stanley-Christian, Systems Chair/Maternal Fetal Medicine at Stroger Hospital, into Its VIP Professional Woman of the Year Circle 2
... that abdominal exercise alone is the best way to improve ... plenty of cardiovascular exercise - to streamline overall body // ... way to those flat abs. , ,Most abdominal exercises ... deposits that sit above them. And, liposuction notwithstanding, there is ...
... Indian Biotech Company, Biocon to colloborate with Nobex ... oral peptide drug for cardiovascular diseases. The spokesperson ... into global research collaboration // on Tuesday for ... cardiovasculoar diseases. The Biocon press release said, “The ...
... Investigators from UCLA had found that the there is ... and methamphetamine use in onset, pattern and duration of ... or self-reported, responses to cocaine peak and decline more ... two stimulants are similar at onset but responses to ...
... test is all set to measure the iron deficiency ... recent issue of the Journal of the American Medical ... 10 percent // of children of one to two ... because iron deficiency can impair infant mental development, possibly ...
... with a mutation in the gene BRCA1, which predisposes them to ... disease if they lose at least 10 pounds (4.5g) between 18 ... from five different countries who all had a mutation in one ... ,Around one in 200 women has a mutation in at least ...
... continues to daily kill a few more people in Uttar ... like Nepal., ,In this special report we review encephalitis ... some essential information on its history, its spread, its life ... mention of Japanese encephalitis occurred during the “summer encephalitis” outbreaks ...
Cached Medicine News:Health News:New Blood Test To Detect Iron Level In Infants 2Health News:Brain Fever or Encephalitis Spreading in North India 2
... been providing excellence in Ambulatory ECG ... of physicians in the diagnosis and ... conditions each year. State-of-the-art equipment and ... the highest standard of customer service ...
... CardioNet has developed a new, ... which allows heartbeat-by-heartbeat, ECG monitoring, analysis ... 24/7/365. Our service is initially focused ... patients with arrhythmia. Time is of ...
... The THERMOstar is a high performance ... 4 microplates. Temperature, shaking speed and incubation ... while the status parameters are displayed on ... plates above and below the microplates provide ...
... The iEMS Incubator/Shaker HT ... Thus, the iEMS Incubator/Shaker HT ... as DNA hybridization and primer ... is available as a one-cabinet ...
Medicine Products: